Conte aos seus amigos sobre este item:
Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy Elisabeth Bergen 2011 edition
Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy
Elisabeth Bergen
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.
110 pages, biography
| Mídia | Livros Paperback Book (Livro de capa flexível e brochura) |
| Lançado | 25 de fevereiro de 2013 |
| ISBN13 | 9783034803182 |
| Editoras | Springer Basel |
| Páginas | 110 |
| Dimensões | 155 × 235 × 7 mm · 181 g |
| Idioma | Alemão |
| Editor | Bartsch, Rupert |
| Editor | Grunt, Thomas W. |
| Editor | Sibilia, Maria |
| Editor | Zielinski, Christoph C. |